Injection · 2 mg
Semaglutide Injection 2 mg
Weekly GLP-1 receptor agonist injection used in type 2 diabetes care and medically supervised weight management.
Prescription-status medicine in the USA, UK, Australia and New Zealand. Use only with a clinician’s advice.
Select pack size
- Tracked delivery included
- 6 to 15 business days
- US · UK · AU · NZ
Semaglutide injection is a glucagon-like peptide-1 (GLP-1) receptor agonist. It copies some of the actions of the natural GLP-1 hormone that helps coordinate insulin release, appetite and how quickly the stomach empties.
Clinicians may prescribe injectable semaglutide for adults with type 2 diabetes when diet and exercise are not enough, and — where the specific product is licensed for it — as part of a chronic weight-management plan. It is not insulin and it is not a substitute for a complete treatment programme.
Global Medica Store ships this 2 mg vial presentation to customers in the United States, United Kingdom, Australia and New Zealand. Dose, titration and injection technique must be set by a qualified healthcare professional.
Key points
- GLP-1 receptor agonist in injectable form
- Used for type 2 diabetes under medical supervision
- May support appetite control when prescribed for weight management
- Once-weekly schedules are common for licensed injectable products
- Discreet delivery to USA, UK, Australia and New Zealand
How it works
After injection, semaglutide binds GLP-1 receptors. When blood glucose is high it can increase insulin secretion and lower glucagon. It also slows gastric emptying and can reduce hunger, which is why many patients notice smaller portions. Response varies, and hypoglycaemia risk rises if it is combined with insulin or sulfonylureas.
Use only as your prescriber directs. Licensed weekly pens are typically started at a low dose and increased slowly to limit nausea. Inject into the abdomen, thigh or upper arm, rotating sites. Do not share pens or vials. Store according to the leaflet — many presentations need refrigeration before first use.
Not for type 1 diabetes or diabetic ketoacidosis. People with a personal or family history of medullary thyroid carcinoma or MEN2 are usually advised to avoid GLP-1 agonists. Common effects include nausea, vomiting, diarrhoea, constipation and reduced appetite. Seek urgent care for severe abdominal pain (possible pancreatitis), signs of a serious allergic reaction, or trouble swallowing. This medicine is prescription-only in the USA, UK, Australia and New Zealand.
| Active ingredient | Semaglutide |
|---|---|
| Strength | 2 mg |
| Form | Solution for injection |
| Packaging | Vial |
| Typical delivery | 6–15 business days |
| Ships to | USA, UK, Australia, New Zealand |
What is semaglutide injection used for?
It is prescribed for type 2 diabetes and, with certain licensed products, for chronic weight management in eligible adults. Your clinician decides whether it is appropriate.
How is the 2 mg injection taken?
Follow the product leaflet and your prescriber. Many branded weekly injections are given subcutaneously once a week on the same day. Do not change the dose yourself.
Can I buy semaglutide injection for the USA, UK, Australia or New Zealand?
We ship to those four countries. Import rules and prescription requirements still apply. Confirm legality and clinical suitability with a local pharmacist or doctor before ordering.
Does it replace a healthy diet?
No. Guidelines pair GLP-1 therapy with nutrition, activity and regular monitoring. Stopping lifestyle measures usually weakens results.
What side effects are most common?
Stomach symptoms — nausea, vomiting, diarrhoea or constipation — especially during dose increases. Report severe or persistent symptoms to a clinician.
